Reported Standalone quarterly numbers for Ipca Laboratories are:Net Sales at Rs 1,485.25 crore in June 2020 up 46.91% from Rs. 1,011.01 crore in June 2019.
Quarterly Net Profit at Rs. 453.64 crore in June 2020 up 243.54% from Rs. 132.05 crore in June 2019.
EBITDA stands at Rs. 599.63 crore in June 2020 up 179.59% from Rs. 214.47 crore in June 2019.
Ipca Labs EPS has increased to Rs. 35.90 in June 2020 from Rs. 10.45 in June 2019.
Ipca Labs shares closed at 1,956.70 on August 07, 2020 (NSE) and has given 55.18% returns over the last 6 months and 110.26% over the last 12 months.
| Ipca Laboratories | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'20 | Mar'20 | Jun'19 | | Net Sales/Income from operations | 1,485.25 | 1,004.79 | 1,011.01 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,485.25 | 1,004.79 | 1,011.01 | | EXPENDITURE | | Consumption of Raw Materials | 362.73 | 371.06 | 321.64 | | Purchase of Traded Goods | 33.37 | 50.85 | 45.91 | | Increase/Decrease in Stocks | 11.34 | -94.97 | -4.98 | | Power & Fuel | -- | -- | -- | | Employees Cost | 241.92 | 227.88 | 205.50 | | Depreciation | 45.23 | 45.38 | 42.04 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 247.94 | 257.25 | 247.90 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 542.72 | 147.34 | 153.00 | | Other Income | 11.68 | 13.30 | 19.43 | | P/L Before Int., Excpt. Items & Tax | 554.40 | 160.64 | 172.43 | | Interest | 2.46 | 3.47 | 4.47 | | P/L Before Exceptional Items & Tax | 551.94 | 157.17 | 167.96 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 551.94 | 157.17 | 167.96 | | Tax | 98.30 | 29.41 | 35.91 | | P/L After Tax from Ordinary Activities | 453.64 | 127.76 | 132.05 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 453.64 | 127.76 | 132.05 | | Equity Share Capital | 25.27 | 25.27 | 25.27 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 35.90 | 10.11 | 10.45 | | Diluted EPS | 35.67 | 10.10 | 10.45 | | EPS After Extra Ordinary | | Basic EPS | 35.90 | 10.11 | 10.45 | | Diluted EPS | 35.67 | 10.10 | 10.45 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Aug 10, 2020 04:33 pm
